Peking University Cancer Hospital
Beijing · Oncology · 3A
Fudan 2022 · #66 3A
Overview
Peking University Cancer Hospital is a leading Chinese hospital located in Beijing, China. It is included in the MedTravelCN Top 100 for its recognized strength in Oncology and its capacity to receive international patients.
A national cancer hospital known for gastrointestinal oncology; its standardised gastric and colorectal cancer pathways are widely adopted.
Key information
| Founded | 1976 |
|---|---|
| City | Beijing |
| Specialty focus | Oncology |
| Accreditation | 3A |
| Fudan 2022 rank | #66 |
Address & location
Leading departments
Ranking trend (Fudan ranking, tier reference)
2021
2022
2023
2024
2025
Tier bands compiled from Fudan China Hospital Ranking releases 2021-2025; for reference only.
Representative experts
- Prof. Ji Jiafu · GI oncology surgery
- Ji Jiafu · GI oncology surgery, gastric cancer
- Shen Lin · GI medical oncology
- GI surgery team · Laparoscopic gastrectomy
- Thoracic oncology team · Targeted and immune therapy
- Breast centre team · Breast-conserving surgery and endocrine therapy
- Radiation oncology team · SBRT and IMRT
Experts compiled from public sources and hospital websites; availability and titles may change — please verify with the hospital before booking.
News & milestones
Multicentre study on standardised gastric cancer surgery
Randomised trials examine lymph-node dissection extent and perioperative therapy.
Molecular subtyping guides precision therapy
Genomic testing matches colorectal and gastric cancer patients to targeted and immune regimens.
Hereditary cancer counselling clinic opens
Genetic testing and risk management for familial breast and colorectal cancer.
Medical team dispatched to Wuhan
Oncology and critical-care staff served in designated hospitals.
SBRT programme expands
SBRT is applied to early lung cancer, liver cancer and oligometastases.
Milestones compiled from credible public reports and official releases; titles are summarized.
International cooperation & exchange
- It joins IGCA multicentre studies and exchanges case discussions with Japanese and Korean gastric cancer centres.
- Trial collaboration with European and US centres includes eligibility assessment for international patients.
- The international office offers English oncology consultation, pathology review and MDT opinions.
International cooperation information compiled from public reports; subject to the hospital's official releases.
University collaboration
Peking University Health Science Center
Research & publications
Leading national work on gastric and colorectal cancer trials, molecular subtyping and targeted therapy.
Compiled from public sources as of October 2026. Please verify details on the hospital's official website before travel.